纽约——拜耳于10月29日赢得了一场审判，驳回了三名女性声称其除草剂Roundup导致她们癌症的指控，同时该公司正等待另一法院对其72.5亿美元（90亿新元）和解计划的更广泛裁决。
NEW YORK – Bayer won a trial on Oct 29 over claims by three women that its Roundup weedkiller caused their cancer, while awaiting a broader ruling from a separate court on the company’s US$7.25 billion (S$9 billion) effort to settle other Roundup cases.
此次审判是对美国最高法院作出有利于拜耳的裁决后，原告能够提出的法律主张受到限制的情况下，Roundup诉讼持续可行性的考验。
The trial was a test for the continued viability of Roundup lawsuits after a US Supreme Court ruling in Bayer’s favour limited the legal claims that plaintiffs can bring.
拜耳还在通过一项提议的72.5亿美元和解方案，试图解决数万起其他Roundup诉讼，该方案正接受密苏里州圣路易斯一名州法院法官的审查。
Bayer is also separately seeking to resolve tens of thousands of other Roundup lawsuits through a proposed US$7.25 billion settlement, which is under review by a Missouri state court judge in St Louis.
在最高法院6月裁决后，圣路易斯陪审团一致裁定拜耳旗下的孟山都胜诉，这是该裁决后首起进入审判的案件。自拜耳于2018年收购孟山都以来，这场诉讼一直给拜耳带来压力，耗费公司数十亿美元并导致其股价下跌。
A St Louis jury unanimously ruled for Bayer-owned Monsanto in the first case to go to trial after June’s Supreme Court ruling. The litigation has weighed on Bayer since its 2018 acquisition of Monsanto, costing the company billions of dollars and driving down its share price.
拜耳股价上涨4%，在格林尼治标准时间1011时（新加坡时间18:11）触及一个月来的最高点。
Bayer shares rose 4% to a one-month high at 1011 GMT (6.11pm in Singapore).
法兰克福联合投资的投资组合经理Markus Manns表示，此判决是公司最重要的审判胜利之一。
Markus Manns, a portfolio manager at Frankfurt-based Union Investment, said the verdict was one of the most important trial wins for the company.
他说：“原告在其新诉讼策略中未能证明拜耳在草甘膦研发阶段就已忽视风险。”
“Plaintiffs have failed in their new litigation strategy to prove that Bayer had ignored the risks as early as the development stage of glyphosate,” he said.
拜耳美国总法律顾问兼全球诉讼负责人Bill Dodero表示，该判决显示在最高法院裁决之后，其他原告要赢得案件将十分困难。
Bill Dodero, Bayer’s US general counsel and global head of litigation, said the verdict showed how difficult it would be for other plaintiffs to win cases after the Supreme Court ruling.
他在声明中说：“此判决应向那些在Durnell裁决后希望通过法院系统追索的原告发出强烈信号——他们在证明自身主张具备可行性以及提供必要证据以在法庭上证明主张方面都将面临重大挑战。”
“This verdict should send a strong signal that plaintiffs who wish to pursue claims in the court system following the Durnell ruling will face significant challenges both in demonstrating they have viable claims and putting forth the necessary evidence to prove them in court,” he said in a statement.
原告特蕾莎·阿雷蒂诺、辛西娅·费尔南德斯和贝蒂·拉金于2020年在圣路易斯起诉拜耳旗下的孟山都公司，称她们经常使用“农达”除草剂，后来患上了非霍奇金淋巴瘤。她们的律师辩称，“农达”设计缺陷且存在不合理危险，拜耳销售该产品属于疏忽行为。
Plaintiffs sued in 2020 Plaintiffs Theresa Aretino, Cynthia Fernandez and Betty Larkin sued Bayer unit Monsanto in 2020 in St Louis, saying they used Roundup regularly and later developed non-Hodgkin lymphoma. Their attorneys argued that Roundup was defectively designed and unreasonably dangerous, and that Bayer was negligent in selling it.
这三名女性未参与拜耳提出的和解方案。费尔南德斯在审判开始前去世。
The three women are not participating in Bayer’s proposed settlement. Fernandez died before the trial began.
路透社通过“法庭视野网”观看了审判和裁决过程。阿雷蒂诺、费尔南德斯和拉金的律师在10月29日晚间未立即回应置评请求。
Reuters viewed the trial and verdict on Courtroom View Network. Attorneys for Aretino, Fernandez and Larkin did not immediately respond to a request for comment late on Oct 29.
拜耳否认相关指控，并表示数十年的研究表明，“农达”的活性成分草甘膦是安全的，不会致癌。
Bayer has denied the claims and said that decades of studies have shown glyphosate, Roundup’s active ingredient, is safe and does not cause cancer.
拜耳在美国州法院和联邦法院面临约6.5万起诉讼，原告称在家庭或工作中使用“农达”后患上癌症。
Bayer faces around 65,000 claims in US state and federal courts from plaintiffs who say they developed cancer after using Roundup at home or on the job.
在2026年美国最高法院作出裁决前，大多数诉讼指控“农达”标签未警示消费者癌症风险。但最高法院于6月驳回了这些法律论点，裁定联邦法律要求除草剂制造商必须使用美国环境保护局（EPA）批准的确切标签。EPA认定“农达”标签无需癌症警示。
Before the Supreme Court ruling in 2026, most lawsuits had alleged that Roundup’s label failed to warn consumers about cancer risks. But the court blocked those legal arguments in June, ruling that federal law requires herbicide makers to use the exact label approved by the US Environmental Protection Agency. The EPA has concluded that Roundup’s label does not require a cancer warning.
拜耳辩称，包括设计缺陷和疏忽在内的其他法律主张，也因美国最高法院的裁决而被排除；但原告律师辩称，这些主张不受该裁决影响。
Bayer has argued that other legal claims, including design-defect and negligence, are also foreclosed by the US Supreme Court’s ruling, but plaintiffs’ attorneys have argued that those claims are not affected by the ruling.
EPA此前认定草甘膦“很可能不致癌”，但目前正在进行新一轮安全性审查。
The EPA has previously concluded that glyphosate is probably not carcinogenic, but it is in the middle of a new review of its safety.
2015年，国际癌症研究机构（IARC）认定草甘膦对人类“可能致癌”，但拜耳称这是基于有缺陷方法论的异见。
In 2015, the International Agency for Research on Cancer concluded that glyphosate was “probably carcinogenic” to humans, but Bayer has said that is an outlier opinion based on flawed methodology.